April 19, 2026 8:40 AM - 9:40 AM PT

In-Person & Virtual

Chair: Laura M. Periman, MD 

Faculty: Kristin Barnes, OD; Selina McGee, OD, FAAO; Neda Shamie, MD

Overview

The TFOS DEWS III initiative released new evidence-based reports in 2025 regarding the diagnosis and management of dry eye disease (DED), creating an opportunity for eye care clinicians to update their care for patients with dry eye. In this program, expert faculty will provide key insights into these reports and perspectives on how to best incorporate new mechanisms of action, including neuromodulation and anti-inflammatory approaches, to alleviate DED.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize the clinically relevant updates on the diagnosis and management of DED in the 2025 TFOS DEWS III reports
• Describe the neural network that monitors the ocular surface environment and regulates tear secretion
• Evaluate the mechanisms, safety, efficacy, and ease of use of therapies that address DED and etiologic factors
• Develop individualized treatment plans for optimal management of DED in cataract and contact lens patients

Target Audience

This educational activity is directed toward optometrists and ophthalmic surgeons who treat patients with eye conditions and disorders. Other eye care specialists and health care professionals interested in the treatment of ocular diseases are invited to participate.

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is accredited by COPE to provide continuing education to optometrists.

Physicians’ Education Resource®, LLC, designates this activity for a maximum of 1.0 COPE credit.

Acknowledgement of Educational Grant Support

This activity is supported by an educational grant from Alcon Laboratories Inc.